Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 6511
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 150MG/12,5MG TBL FLM 98
0028648 EU/1/06/377/016 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 98
0028647 EU/1/06/377/022 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 84
0028646 EU/1/06/377/021 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 56X1
0028645 EU/1/06/377/020 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 56
0028644 EU/1/06/377/019 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 28
0028643 EU/1/06/377/018 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL FLM 14
0028642 EU/1/06/377/017 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/12,5MG TBL NOB 14
0028641 EU/1/06/377/006 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA 300MG/25MG TBL FLM 98
0028659 EU/1/06/377/028 irbesartan.pdf irbesartan.pdf C09DA04 R
IRBESARTAN MYLAN 300MG TBL NOB 100 II
0235406 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 60 II
0235407 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 14 KAL II
0235408 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 28 KAL II
0235409 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 56 KAL II
0235410 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 84 KAL II
0235411 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 300MG TBL NOB 98 KAL II
0235412 58/ 070/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 150MG TBL NOB 30
0235339 58/ 069/12-C irbesartan.pdf irbesartan.pdf C09CA04 R
IRBESARTAN MYLAN 150 MG 150MG TBL NOB 10 I
0235340 58/ 069/12-C     C09CA04 B
IRBESARTAN MYLAN 150 MG 150MG TBL NOB 14 I
0235341 58/ 069/12-C     C09CA04 B
IRBESARTAN MYLAN 150 MG 150MG TBL NOB 28 I
0235342 58/ 069/12-C     C09CA04 B

‹‹ ‹ 50 60 70 80 90 97 98 99 100 101 102 103 104 105 106 107 110 120 130 140 150 200 300 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 13. April 2021 at 01:08
Last update of price and payment data: 8. April 2021 at 01:09